What are Aclaris Therapeutics's profit margins?

Aclaris Therapeutics (ACRS) runs a 76.3% gross margin and a -961.9% operating margin, with a -832.6% net margin.

Where do Aclaris Therapeutics's ratios come from?

Every ratio is computed from Aclaris Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Aclaris Therapeutics ACRS Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	76.3%-9.7pp	73.3%-11.8pp	85.6%-4.0pp	85.8%-4.8pp	86%-3.0pp
Operating margin	-961.9%-168pp	-975.9%-218pp	-973.9%-803pp	-873.4%-663pp	-793.6%-516pp
Net margin	-832.6%-100pp	-829.6%-124pp	-900%-763pp	-802%-619pp	-732.4%-484pp
EBITDA margin	-956.8%-167pp	-970.1%-216pp	-970.8%-803pp	-870.1%-662pp	-789.7%-515pp
Free cash flow margin	-624.9%—	-603.4%—	-273.2%—	——	——
Returns
Return on equity	-48.4%+42.6pp	-50.2%+34.3pp	-113.2%-87.4pp	-101.4%-64.0pp	-91%-42.6pp
Return on assets	-35.1%+34.9pp	-34.1%+29.1pp	-79.2%-60.7pp	-76.9%-47.3pp	-70%-31.7pp
Return on invested capital	-69%+55.9pp	-69.8%+41.8pp	-168.2%-123pp	-131.8%-80.9pp	-124.9%-54.2pp
Efficiency
Asset turnover	0×-0.1×	0×0.0×	0.1×0.0×	0.1×-0.1×	0.1×-0.1×
Liquidity
Current ratio	4×-1.0×	3.4×-0.6×	3.9×-3.1×	3.9×-3.6×	5.1×-1.7×
Quick ratio	4×-1.0×	3.4×-0.6×	3.9×-3.1×	3.9×-3.6×	5.1×-1.7×
Cash ratio	1×-0.4×	0.7×-0.1×	1×-1.5×	0.9×-0.5×	1.4×-0.4×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$1.12-5.3%	$0.84-58.2%	$0.98-46.3%	$1.07-42.7%	$1.18-41.1%
Valuation
Market capitalization	$685.75M+337%	$326.12M+22.9%	$205.83M+151%	$164.59M+110%	$165.47M+88.1%
Enterprise value	$659.07M+410%	$308.28M+26.6%	$182.82M+393%	$141.55M+142%	$137.59M+148%
Price / sales	82×+73.1×	41.7×+27.5×	13.1×+10.0×	9.8×+7.4×	9.3×+6.5×
Price / book	4.8×+3.7×	3.2×+1.5×	1.7×+1.1×	1.2×+0.7×	1.1×+0.5×
EV / sales	78.8×+71.5×	39.4×+26.4×	11.6×+10.2×	8.4×+6.6×	7.7×+6.0×
Free cash flow yield	-7.6%—	-14.5%—	-20.9%—	——	——
Earnings yield	-10.2%+72.8pp	-19.9%+29.9pp	-68.8%-23.7pp	-81.8%-7.0pp	-78.7%+9.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Aclaris Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Aclaris Therapeutics's profit margins?: Aclaris Therapeutics (ACRS) runs a 76.3% gross margin and a -961.9% operating margin, with a -832.6% net margin.
Where do Aclaris Therapeutics's ratios come from?: Every ratio is computed from Aclaris Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.